Knight Therapeutics is a Canadian specialty pharmaceutical company listed on the Toronto Stock Exchange. The company focuses on acquiring, licensing, and selling innovative prescription and over-the-counter pharmaceutical products in Canada and select international markets, while also conducting late-stage clinical development on low-risk, low-expense product opportunities. Knight's products are all sourced through partnerships.
Knight Therapeutics's ticker is GUD
The company's shares trade on the ASX stock exchange
They are based in Altona North, Australia
There are 1001-5000 employees working at Knight Therapeutics
It is gud-knight.com/overview
Knight Therapeutics is in the Industrial Goods sector